Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Phibro Animal Health Corporation (PAHC) had Cost of Goods Sold of $704.59M for the most recently reported fiscal year, ending 2024-06-30.

Quarterly Annual

Figures for fiscal year ending 2024-06-30

Income Statement Financials
Revenue	$1.02B
Net Income	$2.42M
Cost of Goods Sold	$704.59M
Gross Profit	$313.09M
Operating Expenses	$964.36M
Operating Income	$53.31M
Non-Operating Income/Expense	$-42.40M
Pre-Tax Income	$10.92M
Normalized Pre-Tax Income	$10.92M
Income after Taxes	$2.42M
Income from Continuous Operations	$2.42M
Consolidated Net Income/Loss	$2.42M
Normalized Income after Taxes	$2.42M
EBIT	$53.31M
EBITDA	$90.53M
Weighted-Average Shares Outstanding (Basic)	40.50M
Weighted-Average Shares Outstanding (Diluted)	40.52M
Earnings per Share (EPS) (Basic)	$0.06
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$601.00M
Property, Plant, and Equipment	$203.30M
Long-Term Assets	$381.19M
Total Assets	$982.18M
Current Liabilities	$204.15M
Long-Term Debt	$458.29M
Long-Term Liabilities	$521.39M
Total Liabilities	$725.54M
Common Equity	$256.64M
Tangible Shareholders Equity	$157.05M
Shareholders Equity	$256.64M
Common Shares Outstanding	40.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$87.59M
Cash Flow from Investing Activities	$-48.19M
Cash Flow from Financial Activities	$-6.77M
Beginning Cash	$41.28M
End Cash	$70.61M
Increase/Decrease in Cash	$29.33M
Stock-Based Compensation	$0.47M
Common Stock Dividends Paid	$-19.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.64
Debt to Equity Ratio	1.90
Gross Margin	30.77%
Operating Margin	5.24%
EBIT Margin	5.24%
EBITDA Margin	8.90%
Pre-Tax Profit Margin	1.07%
Profit Margin	0.24%
Free Cash Flow	$46.36M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.04
Inventory Turnover	2.65
Receiveable Turnover	6.01
Days Sales in Receivables	60.78
Return on Equity	0.94%
Return on Tangible Equity	1.54%
Return on Assets	0.25%
Return on Investments	0.34%
Book Value Per Share	$6.34
Free Cash Flow per Share	$1.14
Operating Cash Flow per Share	$2.16

Data from Zacks Investment Research, Inc.